Product Description

LCLAT1 Polyclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: BS65808-50, BS65808-100

Product: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Swiss-Prot: Q6UWP7

Host: Rabbit

Reactivity: Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep,

Applications: WB,

All Applications: WB=1:500-2000

Background: Acyl-CoA:lysocardiolipin acyltransferase. Possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. Recognizes both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. Acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. Converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. Required for establishment of the hematopoietic and endothelial lineages.

Purification and Purity: affinity purified by Protein A

Storage and Stability: Store at 4°C short term. Aliquot and store at -19°C long term. Avoid freeze-thaw cycles.

Specificity: LCLAT1 Polyclonal Antibody detects endogenous levels of LCLAT1 protein.

Bioworld Molecular Weight: ~49 kDa

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Primary: Anti-LCLAT1at 1/300 dilution, Primary: Anti-LCLAT1at 1/300 dilution, Primary: Anti-LCLAT1 at 1/1000 dilution

Alternative Name: 1-acylglycerol-3-phosphate O-acyltransferase 8; 1-AGP acyltransferase 8; 1-AGPAT 8; 1AGPAT8; Acyl-CoA:lysocardiolipin acyltransferase 1; AGPAT8; ALCAT1; HSRG1849; lclat1; LCLT1_HUMAN; LYCAT; Lysocardiolipin acyltransferase 1; UNQ1849; UNQ1849/PRO3579

Immunogen: KLH conjugated synthetic peptide derived from human LCLAT1:261-360/414

Conjugate: Unconjugated

Modification: Unmodified